# Nurix Therapeutics

NX-5948 is a CNS-penetrant catalytic BTK degrader that breaks established design rules for CNS drugs, opening B-cell malignancies with CNS involvement.

Source: https://en.bioecon.ru/companies/nurix-therapeutics/
Updated: 2026-07-20

- Country: United States
- Ticker: NRIX

## Technologies

- [PROTACs (targeted protein degradation)](https://en.bioecon.ru/technology/protacs/)